Evidence map›Paper›PMID 30304063›Full record

ArticlePLoS pathogens2018

IFN-γ immune priming of macrophages in vivo induces prolonged STAT1 binding and protection against Cryptococcus neoformans.

Chrissy M Leopold Wager, Camaron R Hole, Althea Campuzano, Natalia Castro-Lopez, Hong Cai, Marley C Caballero Van Dyke, Karen L Wozniak, Yufeng Wang, Floyd L Wormley

Abstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. IFN-γ-Driven macrophage responses in the immunity toFrontiers in cellular and infection microbiology · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Inbred Mouse Models inJournal of fungi (Basel, Switzerland) · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Chrissy M Leopold WagerDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0002-3828-055X
Camaron R HoleDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.
Althea CampuzanoDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0003-3159-7113
Natalia Castro-LopezDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0002-8371-3350
Hong CaiDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.
Marley C Caballero Van DykeDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0002-0332-9173
Karen L WozniakDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0003-1798-2146
Yufeng WangDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.
Floyd L WormleyDepartment of Biology, The University of Texas at San Antonio, San Antonio, TX, United States of America.ORCID 0000-0001-9290-3925

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
Protective Host Immunity Against Pulmonary CryptococcosisR01AI071752 · NIAID · UNIVERSITY OF TEXAS SAN ANTONIO · PI WORMLEY, FLOYD L. · 2007 to 2018
$3.7M
Systems Biology of Plasmodium falciparum: Building and Exploring Network ModelsSC1GM100806 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI WANG, YUFENG · 2012 to 2015
$1.5M
NIAID NIH HHS R01 AI071752NIGMS NIH HHS R25 GM060655NIGMS NIH HHS SC1 GM100806
6 · The paper itself

Abstract

Development of vaccines against opportunistic infections is difficult as patients most at risk of developing disease are deficient in aspects of the adaptive immune system. Here, we utilized an experimental immunization strategy to induce innate memory in macrophages in vivo. Unlike current trained immunity models, we present an innate memory-like phenotype in macrophages that is maintained for at least 70 days post-immunization and results in complete protection against secondary challenge in the absence of adaptive immune cells. RNA-seq analysis of in vivo IFN-γ primed macrophages revealed a rapid up-regulation of IFN-γ and STAT1 signaling pathways following secondary challenge. The enhanced cytokine recall responses appeared to be pathogen-specific, dependent on changes in histone methylation and acetylation, and correlated with increased STAT1 binding to promoter regions of genes associated with protective anti-fungal immunity. Thus, we demonstrate an alternative mechanism to induce macrophage innate memory in vivo that facilitates pathogen-specific vaccine-mediated immune responses.

Indexed as

AnimalsCryptococcosisCryptococcus neoformansCytokinesFemaleInterferon-gammaLung Diseases, FungalMacrophage ActivationMacrophages, AlveolarMiceMice, Inbred BALB CSignal TransductionSTAT1 Transcription FactorCytokinesInterferon-gammaStat1 protein, mouseSTAT1 Transcription Factor

Identifiers

PMID30304063
PMCPMC6197699

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.